US 11,891,448 B2
Glycated CD59 peptides, their preparation, and uses thereof
Jose A. Halperin, Brookline, MA (US); and Michael Chorev, Chestnut Hill, MA (US)
Assigned to President and Fellows of Harvard College, Cambridge, MA (US)
Filed by President and Fellows of Harvard College, Cambridge, MA (US)
Filed on Nov. 1, 2021, as Appl. No. 17/516,508.
Application 15/995,370 is a division of application No. 14/724,911, filed on May 29, 2015, abandoned.
Application 14/724,911 is a division of application No. 13/818,775, granted, now 9,068,006, issued on Jun. 30, 2015, previously published as PCT/US2011/049118, filed on Aug. 25, 2011.
Application 17/516,508 is a continuation of application No. 15/995,370, filed on Jun. 1, 2018, granted, now 11,161,910.
Claims priority of provisional application 61/377,060, filed on Aug. 25, 2010.
Prior Publication US 2022/0162333 A1, May 26, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/28 (2006.01); G01N 33/68 (2006.01); C07K 14/705 (2006.01)
CPC C07K 16/2896 (2013.01) [C07K 14/70596 (2013.01); G01N 33/6842 (2013.01); G01N 33/6872 (2013.01); C07K 2317/34 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); G01N 2333/70596 (2013.01); G01N 2440/38 (2013.01); G01N 2800/042 (2013.01)] 8 Claims
 
1. A glycated peptide comprising:

OG Complex Work Unit Chemistry
or a protected form thereof.